Article
Organometallics, Vol. 29, No. 6, 2010 1485
CDCl3): δ 7.48-7.18 (m, 4 H, Ar-H), 4.74 (s, 2 H, CH2), 3.46
Complexes cis-7a, trans-anti-7a, and trans-syn-7a. Ag2O
(0.116 g, 0.5 mmol) was added to a solution of 5a (0.299 g,
1 mmol) in CH2Cl2 (5 mL) and stirred overnight at ambient
temperature. The reaction mixture was then filtered and added
to a solution of trans-[PdBr2(CH3CN)2] (0.133 g, 0.5 mmol) in
CH3CN. The suspension was stirred overnight at ambient
temperature and filtered to remove AgBr. The volatiles were
then removed in vacuo, and the residue was washed with diethyl
ether. Acetone was added, upon which a yellow precipitate
formed upon stirring. The yellow precipitate was filtered,
washed with small amounts of acetone, and dried in vacuo,
affording a mixture of trans-anti-7a and trans-syn-7a. The
solvent in the acetone filtrate was removed in vacuo, and CHCl3
was added to the off-white residue. Upon standing and slow
evaporation of CHCl3 cis-7a precipitates. cis-7a, 0.157 g
(0.223 mmol), 45% yield. trans-anti-7a þ trans-syn-7a, 0.187 g
(0.266 mmol), 53% yield. Anal. Calcd for C24H28Br2N4S2Pd: C,
41.01; H, 4.02; 7.97. Found: C, 40.30; H, 4.07; N, 8.00. 1H NMR
(300 MHz, CDCl3): δ 7.59-6.74 (m, 24 H, Ar-H), 5.90 (s, 4 H,
CH2), 5.71 (s, 4 H, CH2), 4.13 (s, 6 H, NCH3), 3.99 (s, 6 H,
NCH3), 2.52 (s, 6 H, SCH3), 2.37 (s, 6 H, SCH3). 13C{1H} NMR
(75.47 MHz, CDCl3): 169.9 (NCN), 169.8 (NCN), 137.3, 137.1,
134.7, 134.5, 130.5, 130.4, 128.9, 128.7, 126.6, 126.3, 126.1, 125.9
(Ar-C), 122.5, 122.4, 121.2, 121.0 (NCH), 51.6 (CH2), 51.5
(CH2), 38.2 (NCH3), 38.1 (NCH3), 16.5 (SCH3), 16.3 (SCH3).
MS (ESI, positive ions) m/z (%): 623 (100) [M - Br]þ.
Complexes trans-anti-7b and trans-syn-7b. Ag2O (0.116 g,
0.5 mmol) was added to a solution of 5b (0.327 g, 1 mmol) in
CH2Cl2 (5 mL) and stirred overnight at ambient temperature.
The reaction mixture was then filtered and added to a solution of
trans-[PdBr2(CH3CN)2] (0.133 g, 0.5 mmol) in CH3CN. The
reaction mixture was stirred overnight at ambient temperature
and filtered to remove AgBr. The solvent of the filtrate was
removed in vacuo and the residue washed with diethyl ether and
methanol. trans-anti-7b selectively crystallized from a CH2Cl2
solution. trans-anti-7b þ trans-syn-7b, 0.207 g (0.273 mmol),
54% yield. Anal. Calcd for C28H36Br2N4S2Pd: C, 44.31; H, 4.78;
N, 7.38. Found: C, 44.80; H, 4.90; N, 7.36. 1H NMR (300 MHz,
CDCl3): δ 7.61-6.72 (m, 24 H, Ar-H), 6.01 (s, 4 H, CH2), 5.88
(s, 4 H, CH2), 4.15 (s, 6 H, NCH3), 3.99 (s, 6 H, NCH3), 3.41 (sep,
3J(H,H) = 6.7 Hz, 2 H, CH), 3.27 (sep, 3J(H,H) = 6.6 Hz, 2 H,
CH), 1.34 (d, 3J(H,H) = 6.6 Hz, 12 H, CH3), 1.22 (d, 3J(H,H) =
6.8 Hz, 12 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 169.8
(NCN), 169.7 (NCN), 138.3, 138.2, 134.4, 134.3, 133.2, 133.1,
130.8, 130.6, 128.5, 128.4, 128.1, 128.0 (Ar-C), 122.6, 121.0
(NCH), 51.9 (CH2), 51.8 (CH2), 39.2 (NCH3), 39.1 (NCH3), 38.2
(CH), 38.1 (CH), 23.3 (CH3), 23.2 (CH3). MS (ESI, positive
ions) m/z (%): 679 (100) [M - Br]þ.
3
3
(sep, J(H,H) = 6.6 Hz, 1 H, CH), 1.32 (d, J(H,H) = 6.6 Hz,
6 H, CH3).
Imidazolium Salts 5a and 5b. 4a or 4b (10 mmol) was added to
a solution of 1-methylimidazole (0.80 mL, 10 mmol) in toluene.
The reaction mixture was stirred overnight at 80 °C. An
immiscible layer was formed and the toluene was decanted.
The remaining yellow oil was washed with toluene and diethyl
ether and subsequently dried in vacuo. 5a solidifies in the
refrigerator overnight, giving a white hygroscopic solid, whereas
5b was obtained as viscous yellow oil. 5a, 2.878 g (9.62 mmol),
78% yield. 1H NMR (300 MHz, CDCl3): δ 10.37 (s, 1 H,
NCHN), 7.65 (dd, 3J(H,H) = 7.5 Hz, 4J(H,H) = 1.2 Hz, 1 H,
Ar-H), 7.43-7.22 (m, 5 H, Ar-H þ CHImd), 5.64 (s, 2 H, CH2),
4.10 (s, 3 H, NCH3), 2.50 (s, 3 H, SCH3). 13C{1H} NMR (75.47
MHz, CDCl3): δ 138.4 (NCN), 137.4, 131.2, 130.7, 130.5, 127.0,
126.2 (Ar-C), 123.4, 121.8 (CHImd), 51.1 (CH2), 36.8 (NCH3),
16.1 (SCH3). MS (ESI, positive ions) m/z (%): 219 (100) [M -
Br]þ. 5b, 3.118 g (9.53 mmol), 76% yield. 1H NMR (300 MHz,
CDCl3): δ 10.26 (s, 1 H, NCHN), 7.72 (dd, 3J(H,H) = 7.4 Hz,
4J(H,H) = 1.7 Hz, 1 H, Ar-H), 7.55-7.16 (m, 5 H, Ar-H þ
CHImd), 5.72 (s, 2 H, CH2), 4.10 (s, 3 H, NCH3), 3.40 (sep, 3J(H,
H) = 6.6 Hz, 1 H, CH), 1.29 (d, 3J(H,H) = 6.7 Hz, 6 H, CH3).
13C{1H} NMR (75.47 MHz, CDCl3): δ 137.2 (NCN), 135.6,
134.1, 133.0, 131.3, 130.1, 128.1 (Ar-C), 123.4, 121.7 (CHImd),
51.3 (CH2), 39.4 (NCH3), 36.8 (CH), 22.9 (CH3). MS (ESI,
positive ions) m/z (%): 247 (100) [M - Br]þ.
Benzimidazolium Salt 6a. 4a (0.637 g, 2.93 mmol) was added
to a solution of 1-methylbenzimidazole (0.338 g, 2.56 mmol) in
toluene (5 mL). The reaction mixture was stirred overnight at
90 °C. The white precipitate formed was filtered and washed
with toluene and diethyl ether. The product was dried in vacuo,
giving a white powder. 6a, 0.623 g (1.78 mmol), 70% yield. 1H
NMR (300 MHz, CDCl3): δ 11.25 (s, 1 H, NCHN), 7.69-7.51
(m, 5 H, Ar-H), 7.40-7.31 (m, 2 H, Ar-H), 7.25-7.20 (m, 1 H,
Ar-H), 5.88 (s, 2 H, CH2), 4.31 (s, 3 H, NCH3), 2.51 (s, 3 H,
SCH3). 13C{1H} NMR (75.47 MHz, CDCl3): δ 144.4 (NCHN),
138.6, 132.7, 131.8, 131.0, 130.9, 130.8, 128.1, 127.8, 127.8,
127.0, 114.4, 113.4 (Ar-C), 50.0 (CH2), 34.6 (NCH3), 17.2
(SCH3). MS (ESI): m/z = 269 [M - Br]þ.
Benzimidazolium Salt 6b. 4b (0.544 g, 2.22 mmol) was added
to a solution of 1-methylbenzimidazole (0.268 g, 2.03 mmol) in
toluene (5 mL). The reaction mixture was stirred overnight at
90 °C. The volatiles were removed in vacuo, and the viscous
brown mixture obtained was washed with copious amounts of
diethyl ether. Upon standing in diethyl ether, a white precipitate
formed. The diethyl ether was decanted, and the product was
dried in vacuo to obtain a white powder. 6b, 0.536 g (1.42 mmol),
70% yield. 1H NMR (300 MHz, CDCl3): δ 11.34 (s, 1 H,
NCHN), 7.69-7.49 (m, 6 H, Ar-H), 7.35-7.27 (m, 2 H,
Ar-H), 6.01 (s, 2 H, CH2), 4.30 (s, 3 H, NCH3), 3.36 (sep,
3J(H,H) = 6.7 Hz, 1 H, SCH), 1.28 (d, 3J(H,H) = 6.7 Hz, 6 H,
SCH(CH3)2). 13C{1H} NMR (75.47 MHz, CDCl3): δ 144.3
(NCHN), 135.6, 134.8, 134.6, 132.7, 131.7, 130.9, 130.5, 129.1,
127.8, 114.7, 113.3 (Ar-C, due to accidental overlap only 11
signals are observed), 50.1 (CH2), 40.5 (NCH3), 34.5 (SCH),
23.7 (CH3). MS (ESI): m/z = 297 [M - Br]þ.
Complex cis-7a. Pd(OAc)2 (0.112 g, 0.5 mmol) was added to a
solution of 5a (0.299 g, 1 mmol) in CH3CN (60 mL). The
reaction mixture was stirred overnight at 70 °C and then filtered.
The solvent of the filtrate was removed in vacuo, and the residue
was washed several times with CH2Cl2, affording a white solid of
cis-7a. Due to insufficient solubility of cis-7a, the 1H NMR
spectrum shows broad signals and the 13C NMR spectrum could
not be obtained. cis-7a, 0.136 g (0.193 mmol), 38% yield. Anal.
Calcd for C24H28Br2N4S2Pd: C, 41.01; H, 4.02; 7.97. Found: C,
41.10; H, 3.97; N, 8.02. 1H NMR (300 MHz, CD3CN): δ
7.36-6.82 (m, br, 12 H, Ar-H), 5.45 (brs, 4 H, CH2), 3.87
(brs, 6 H, NCH3), 2.55 (brs, 6 H, SCH3). MS (ESI, positive ions)
m/z (%): 623 (100) [M - Br]þ.
Complex cis-8a. A mixture of salt 6a (0.180 g, 0.52 mmol) and
Pd(OAc)2 (0.056 g, 0.25 mmol) was dissolved in DMSO (10 mL)
and stirred overnight at 90 °C. A clear yellow solution was
obtained. The solvent was removed by vacuum distillation, and
the resulting residue was dissolved in CH2Cl2 (15 mL) and
washed with H2O (4 ꢀ 15 mL). Drying of the organic phase
over Na2SO4 followed by removal of the solvent in vacuo gave a
yellow solid. Subsequent washing with diethyl ether produced a
crystalline yellow powder. Slow evaporation of a saturated
acetonitrile solution afforded the product as yellow crystals.
cis-8a, 0.176 g (0.22 mmol), 89% yield. Anal. Calcd for
C32H32Br2N4S2Pd: C, 47.86; H, 4.02; N, 6.98. Found: C,
48.03; H, 4.07; N, 6.90. 1H NMR (300 MHz, CDCl3): δ
7.24-6.88 (m, 12 H, Ar-H), 6.26-6.00 (m, 4 H, Ar-H), 6.07
(d, 2J(H,H) = 17.2 Hz, 2 H, NCH2), 5.67 (d, 2J(H,H) = 17.2 Hz,
2 H, NCH2), 4.08 (s, 6 H, NCH3), 2.62 (s, 6 H, SCH3). 13C{1H}
NMR (75.47 MHz, CDCl3): δ 175.1 (NCN), 136.4, 135.6, 134.1,
131.8, 128.9, 125.6, 125.1, 124.3, 124.3, 111.6, 111.2 (Ar-C),
50.0 (NCH2), 36.5 (NCH3), 16.2 (SCH3). MS (ESI): m/z = 723
[M - Br]þ.
Complex cis-8b. A mixture of salt 6b (0.415 g, 1.10 mmol) and
Pd(OAc)2 (0.112 g, 0.50 mmol) was dissolved in DMSO (15 mL)